American Society for Clinical Pathology (ASCP) Technologist in Cytogenetics certification (ASCP CG) Practice Test

Disable ads (and more) with a membership for a one time $4.99 payment

Enhance your ASCP CG exam preparation with comprehensive quizzes and resources. Master the content with detailed explanations and expert tips. Excel in your assessment!

Practice this question and more.


How does AML M0 differ from AML M1 in terms of differentiation?

  1. AML M0 has significant differentiation, while AML M1 does not

  2. AML M0 shows no differentiation, unlike AML M1 with some differentiation

  3. Both AML M0 and M1 have the same level of differentiation

  4. AML M1 has higher differentiation compared to AML M0

The correct answer is: AML M0 shows no differentiation, unlike AML M1 with some differentiation

AML M0, classified as acute myeloid leukemia with minimal maturation, is characterized by the presence of undifferentiated myeloid blasts that do not show significant features of differentiation. This lack of maturation indicates that the leukemic cells have not progressed to a more differentiated state, resulting in a homogeneous population of primitive blasts. In contrast, AML M1 is recognized as acute myeloid leukemia with minimal differentiation, where there are some myeloid blasts that do exhibit a degree of maturation. This means that within AML M1, there can be some cells in the lineage showing the beginnings of differentiation toward specific myeloid cell types, though not fully mature. This distinction is crucial in the context of diagnosing and treating these leukemias, as the level of differentiation can impact therapeutic strategies and prognosis. In summary, the critical difference lies in the level of maturation and differentiation observed, with AML M0 showing no differentiation and AML M1 revealing some degree of differentiation in its cellular makeup.